Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PACT: Patient Preferences in Adjuvant Colorectal Cancer Therapy
2005-000686-19Phase 3Completed
- Sponsor
- University of Leeds
- Start
- Apr 2005
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of capecitabine, fluorouracil and folinic acid in colorectal cancer (CRC) (2 arms), sponsored by University of Leeds. Primary endpoint: Patient preference at 12 weeks. Started Apr 2005; status: completed.
02
Drugs
capecitabinefluorouracilfolinic acid
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on 2005-000686-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000686-19.